Blog
Lindblad Expeditions (LIND) Reports Q4 Loss, Tops Revenue Estimates
Lindblad Expeditions (LIND) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.48 per share a year ago. These
Emcor Group (EME) Q4 Earnings and Revenues Top Estimates
Emcor Group (EME) came out with quarterly earnings of $7.19 per share, beating the Zacks Consensus Estimate of $6.68 per share. This compares to earnings of $6.32 per share a year ago. These figures
Shift4 Payments (FOUR) Q4 Earnings Surpass Estimates
Shift4 Payments (FOUR) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.35 per share a year ago. These
FTI Consulting (FCN) Surpasses Q4 Earnings and Revenue Estimates
FTI Consulting (FCN) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.56 per share a year ago. These
Cars.com (CARS) Misses Q4 Earnings Estimates
Cars.com (CARS) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.49 per share a year ago. These figures
Burford Capital Limited (BUR) Reports Q4 Loss, Misses Revenue Estimates
Burford Capital Limited (BUR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of $0.37. This compares to a loss of $0.06 per share a year ago. These figures are
CRA International (CRAI) Q4 Earnings and Revenues Beat Estimates
CRA International (CRAI) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $2.03 per share a year ago. These
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.04 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $1.77 per share a year ago
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates
Anika Therapeutics (ANIK) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.03 per share a year ago. These
ACM Research, Inc. (ACMR) Lags Q4 Earnings Estimates
ACM Research, Inc. (ACMR) came out with quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.56 per share a year ago. These
BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates
BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.13 per share a year ago
BlackSky Technology Inc. (BKSY) Reports Q4 Loss, Lags Revenue Estimates
BlackSky Technology Inc. (BKSY) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.39 per share a year ago. These
Why Heritage Insurance (HRTG) Could Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Heritage Insurance (HRTG), which belongs
2 Home Furnishing Stocks Set to Benefit Despite Industry Odds
Ross Stores Stock Shows Momentum Before Q4 Results: Is a Beat Likely?
Ross Stores, Inc. ROST is likely to post year-over-year top and bottom line growth when it reports fourth-quarter fiscal 2025 earnings on March 3, after market close. The Zacks Consensus Estimate
Super Group (SGHC) (SGHC) Upgraded to Strong Buy: Here's What You Should Know
Investors might want to bet on Super Group (SGHC) Limited (SGHC), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful
Alexander's (ALX) Upgraded to Buy: Here's What You Should Know
Alexander's (ALX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting
Okta (OKTA) Upgraded to Strong Buy: Here's What You Should Know
Okta (OKTA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
Haleon PLC Sponsored ADR (HLN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
Boot Barn (BOOT) Upgraded to Strong Buy: Here's What You Should Know
Boot Barn (BOOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
What Makes Associated British Foods (ASBFY) a New Strong Buy Stock
Investors might want to bet on Associated British Foods PLC (ASBFY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in
EDENRED (EDNMY) Upgraded to Buy: What Does It Mean for the Stock?
EDENRED (EDNMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
Fluor (FLR) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
What Makes Sasol (SSL) a Strong Momentum Stock: Buy Now?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Western Digital (WDC) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell


